Vijaya Diagnostic Centre reports strong Q2 FY26 revenue growth, completes merger

Vijaya Diagnostic Centre Limited reported 10.2% year-over-year revenue growth for Q2 FY26, reaching INR 2,015.6 million, and 14.9% growth for H1 FY26, totaling INR 3,896.1 million. The company's profit after tax (PAT) for Q2 FY26 increased by 2.7% to INR 432.8 million, while H1 FY26 PAT grew by 11.2% to INR 818.7 million. Operational highlights included an 8.3% rise in total tests to 4.28 million and a 5.7% increase in footfall to 1.20 million in Q2 FY26.

The company announced the successful merger of Medinova Diagnostic Services Limited with Vijaya Diagnostic Centre Limited, effective November 4, 2025, following NCLT approval on October 13, 2025. The appointed date for the scheme is April 1, 2024.

As part of the merger, Medinova Millennium MRI Services LLP, a wholly-owned subsidiary of the transferor company, will become a wholly-owned subsidiary of Vijaya Diagnostic Centre. The share exchange ratio for the merger is 1 equity share of INR 1 for every 22 equity shares of INR 10 held in the transferor company, with a record date of November 25, 2025. This merger will also increase the authorized share capital of Vijaya Diagnostic Centre to INR 230,500,000.